In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes

Fasciolosis is considered the most widespread trematode disease affecting grazing animals around the world; it is currently recognised by the World Health Organisation as an emergent human pathogen. Triclabendazole is still the most effective drug against this disease; however, resistant strains hav...

Descripción completa

Detalles Bibliográficos
Autores Principales: Rojas-Caraballo, Jose, López-Abán, Julio, Pérez del Villa, Luis, Vizcaíno, Carolina, Vicente, Belén, Fernández-Soto, Pedro, del Olmo, Esther, Alfonso Patarroyo, Manuel, Muro, Antonio
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: 2014
Materias:
Acceso en línea:http://repository.urosario.edu.co/handle/10336/18685
https://doi.org/10.1371/journal.pone.0105323
id ir-10336-18685
recordtype dspace
spelling ir-10336-186852022-08-29T15:44:53Z In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes Rojas-Caraballo, Jose López-Abán, Julio Pérez del Villa, Luis Vizcaíno, Carolina Vicente, Belén Fernández-Soto, Pedro del Olmo, Esther Alfonso Patarroyo, Manuel Muro, Antonio Cytokine Epitope Helminth Antibody Immunoglobulin G Peptide Protozoal Vaccine Amino Acid Sequence Animal Blood Chemistry Cluster Analysis Disease Model Fasciola Hepatica Fascioliasis Female Gene Expression Profiling Genetics Immunology Metabolism Mortality Mouse Parasitology Synthesis Amino Acid Sequence Animals Fasciola Hepatica Fascioliasis Gene Expression Profiling Mice Peptides Protozoan Vaccines Animal T-Lymphocyte B-Lymphocyte Disease Models Epitopes Epitopes Fasciola hepática Enzimología Parasitología Fasciolosis is considered the most widespread trematode disease affecting grazing animals around the world; it is currently recognised by the World Health Organisation as an emergent human pathogen. Triclabendazole is still the most effective drug against this disease; however, resistant strains have appeared and developing an effective vaccine against this disease has increasingly become a priority. Several bioinformatics tools were here used for predicting B- and T-cell epitopes according to the available data for Fasciola hepatica protein amino acid sequences. BALB/c mice were immunised with the synthetic peptides by using the ADAD vaccination system and several immune response parameters were measured (antibody titres, cytokine levels, T-cell populations) to evaluate their ability to elicit an immune response. Based on the immunogenicity results so obtained, seven peptides were selected to assess their protection-inducing ability against experimental infection with F. hepatica metacercariae. Twenty-four B- or T-epitope-containing peptides were predicted and chemically synthesised. Immunisation of mice with peptides so-called B1, B2, B5, B6, T14, T15 and T16 induced high levels of total IgG, IgG1 and IgG2a (p<0.05) and a mixed Th1/Th2/Th17/Treg immune response, according to IFN-γ, IL-4, IL-17 and IL-10 levels, accompanied by increased CD62L+ T-cell populations. A high level of protection was obtained in mice vaccinated with peptides B2, B5, B6 and T15 formulated in the ADAD vaccination system with the AA0029 immunomodulator. The bioinformatics approach used in the present study led to the identification of seven peptides as vaccine candidates against the infection caused by Fasciola hepatica (a liver-fluke trematode). However, vaccine efficacy must be evaluated in other host species, including those having veterinary importance. © 2014 Rojas-Caraballo et al. 2014 2018-11-07T16:00:25Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 1932-6203 http://repository.urosario.edu.co/handle/10336/18685 https://doi.org/10.1371/journal.pone.0105323 eng info:eu-repo/semantics/openAccess application/pdf instname:Universidad del Rosario
institution EdocUR - Universidad del Rosario
collection DSpace
language Inglés (English)
topic Cytokine
Epitope
Helminth Antibody
Immunoglobulin G
Peptide
Protozoal Vaccine
Amino Acid Sequence
Animal
Blood
Chemistry
Cluster Analysis
Disease Model
Fasciola Hepatica
Fascioliasis
Female
Gene Expression Profiling
Genetics
Immunology
Metabolism
Mortality
Mouse
Parasitology
Synthesis
Amino Acid Sequence
Animals
Fasciola Hepatica
Fascioliasis
Gene Expression Profiling
Mice
Peptides
Protozoan Vaccines
Animal
T-Lymphocyte
B-Lymphocyte
Disease Models
Epitopes
Epitopes
Fasciola hepática
Enzimología
Parasitología
spellingShingle Cytokine
Epitope
Helminth Antibody
Immunoglobulin G
Peptide
Protozoal Vaccine
Amino Acid Sequence
Animal
Blood
Chemistry
Cluster Analysis
Disease Model
Fasciola Hepatica
Fascioliasis
Female
Gene Expression Profiling
Genetics
Immunology
Metabolism
Mortality
Mouse
Parasitology
Synthesis
Amino Acid Sequence
Animals
Fasciola Hepatica
Fascioliasis
Gene Expression Profiling
Mice
Peptides
Protozoan Vaccines
Animal
T-Lymphocyte
B-Lymphocyte
Disease Models
Epitopes
Epitopes
Fasciola hepática
Enzimología
Parasitología
Rojas-Caraballo, Jose
López-Abán, Julio
Pérez del Villa, Luis
Vizcaíno, Carolina
Vicente, Belén
Fernández-Soto, Pedro
del Olmo, Esther
Alfonso Patarroyo, Manuel
Muro, Antonio
In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes
description Fasciolosis is considered the most widespread trematode disease affecting grazing animals around the world; it is currently recognised by the World Health Organisation as an emergent human pathogen. Triclabendazole is still the most effective drug against this disease; however, resistant strains have appeared and developing an effective vaccine against this disease has increasingly become a priority. Several bioinformatics tools were here used for predicting B- and T-cell epitopes according to the available data for Fasciola hepatica protein amino acid sequences. BALB/c mice were immunised with the synthetic peptides by using the ADAD vaccination system and several immune response parameters were measured (antibody titres, cytokine levels, T-cell populations) to evaluate their ability to elicit an immune response. Based on the immunogenicity results so obtained, seven peptides were selected to assess their protection-inducing ability against experimental infection with F. hepatica metacercariae. Twenty-four B- or T-epitope-containing peptides were predicted and chemically synthesised. Immunisation of mice with peptides so-called B1, B2, B5, B6, T14, T15 and T16 induced high levels of total IgG, IgG1 and IgG2a (p<0.05) and a mixed Th1/Th2/Th17/Treg immune response, according to IFN-γ, IL-4, IL-17 and IL-10 levels, accompanied by increased CD62L+ T-cell populations. A high level of protection was obtained in mice vaccinated with peptides B2, B5, B6 and T15 formulated in the ADAD vaccination system with the AA0029 immunomodulator. The bioinformatics approach used in the present study led to the identification of seven peptides as vaccine candidates against the infection caused by Fasciola hepatica (a liver-fluke trematode). However, vaccine efficacy must be evaluated in other host species, including those having veterinary importance. © 2014 Rojas-Caraballo et al.
format Artículo (Article)
author Rojas-Caraballo, Jose
López-Abán, Julio
Pérez del Villa, Luis
Vizcaíno, Carolina
Vicente, Belén
Fernández-Soto, Pedro
del Olmo, Esther
Alfonso Patarroyo, Manuel
Muro, Antonio
author_facet Rojas-Caraballo, Jose
López-Abán, Julio
Pérez del Villa, Luis
Vizcaíno, Carolina
Vicente, Belén
Fernández-Soto, Pedro
del Olmo, Esther
Alfonso Patarroyo, Manuel
Muro, Antonio
author_sort Rojas-Caraballo, Jose
title In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes
title_short In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes
title_full In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes
title_fullStr In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes
title_full_unstemmed In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes
title_sort in vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by fasciola hepatica-derived synthetic peptides containing b- and t-cell epitopes
publishDate 2014
url http://repository.urosario.edu.co/handle/10336/18685
https://doi.org/10.1371/journal.pone.0105323
_version_ 1743431047139295232
score 12,131701